Publication Name	World Journal of Gastroenterology
Manuscript ID	94490
Country	Italy

Received	2024-03-19 10:02
Peer-Review Started	2024-03-19 10:02
To Make the First Decision
Return for Revision	2024-05-01 07:14
Revised	2024-05-10 09:25
Second Decision	2024-05-27 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-05-27 05:01
Articles in Press	2024-05-27 05:01
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-05-30 16:41
Typeset the Manuscript	2024-06-20 05:28
Publish the Manuscript Online	2024-06-25 10:41

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Microbiology
Manuscript Type	Editorial
Article Title	Aspergillus niger prolyl endopeptidase in celiac disease
Manuscript Source	Invited Manuscript
All Author List	Marica Colella, Concetta Cafiero and Raffaele Palmirotta
ORCID	Author(s) ORCID Number Marica Colella http://orcid.org/0000-0003-0806-4327 Concetta Cafiero http://orcid.org/0000-0003-3859-2040 Raffaele Palmirotta http://orcid.org/0000-0002-9401-7377
Funding Agency and Grant Number
Corresponding Author	Raffaele Palmirotta, MD, PhD, Associate Professor, Senior Researcher, Interdisciplinary Department of Medicine, Section of Microbiology and Virology,, University of Bari “Aldo Moro”, P.zza G. Cesare, 11, Bari 70124, Italy. raffaelepalmirotta@gmail.com
Key Words	Celiac disease; Aspergillus niger prolyl endoprotease; Gluten immunogenic peptides; Trial; Symptoms; Real-life trial
Core Tip	Involuntary or voluntary exposure to gluten in long-term gluten-free diet celiac patients could lead to severe and persistent symptoms. Aspergillus niger prolyl endopeptidase is able to metabolize gluten before it arrives into the small intestine, reducing the celiac disease-specific symptoms. It is demonstrated by the decrease in the concentration on gluten immunogenic peptide.
Publish Date	2024-06-25 10:41
Citation	<p>Colella M, Cafiero C, Palmirotta R. Aspergillus niger prolyl endopeptidase in celiac disease. <i>World J Gastroenterol</i> 2024; 30(24): 3044-3047</p>
URL	https://www.wjgnet.com/1007-9327/full/v30/i24/3044.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i24.3044

Full Article (PDF)	WJG-30-3044-with-cover.pdf
Manuscript File	94490_Revision_Auto_Edited.docx
Answering Reviewers	94490-answering-reviewers.pdf
Audio Core Tip	94490-audio.mp3
Conflict-of-Interest Disclosure Form	94490-conflict-of-interest-statement.pdf
Copyright License Agreement	94490-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	94490-non-native-speakers.pdf
Peer-review Report	94490-peer-reviews.pdf
Scientific Misconduct Check	94490-scientific-misconduct-check.jpg
Scientific Editor Work List	94490-scientific-editor-work-list.pdf
CrossCheck Report	94490-crosscheck-report.pdf